Russell 2000 Index Newsroom

The European Commission Has Adopted A Positive Decision For The Designation Of Agios Pharmaceuticals' Mitapivat As An Orphan Medicinal Product For Sickle Cell Disease

Benzingajust now

Barclays Upgrades Transocean to Overweight, Maintains Price Target to $4.5

Benzinga2minutes ago · Ratings

Forecasting The Future: 12 Analyst Projections For Fluence Energy

Benzinga3minutes ago

Transocean Analyst Ratings

Benzinga4minutes ago · Ratings

Oceaneering International Analyst Ratings

Benzinga7minutes ago · Ratings

Valaris Analyst Ratings

Benzinga12minutes ago · Ratings

Krystal Biotech Analyst Ratings

Benzinga17minutes ago · Ratings

Compass Pathways Common Stock To Be Added To The Nasdaq Biotechnology Index

Benzinga32minutes ago

Getty Images Holdings Analyst Ratings

Benzinga32minutes ago · Ratings

ALX Oncology Holdings Analyst Ratings

Benzinga33minutes ago · Ratings

Needham Reiterates Buy on Foot Locker, Maintains $25 Price Target

Benzinga44minutes ago · Ratings

Foot Locker Analyst Ratings

Benzinga47minutes ago · Ratings

HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $68 Price Target

Benzinga48minutes ago · Ratings

Halozyme Therapeutics Analyst Ratings

Benzinga49minutes ago · Ratings

Kosmos Energy Analyst Ratings

Benzinga50minutes ago · Ratings

HC Wainwright & Co. Reiterates Buy on RCI Hospitality Hldgs, Maintains $98 Price Target

Benzinga52minutes ago · Ratings

RCI Hospitality Hldgs Analyst Ratings

Benzinga54minutes ago · Ratings

HC Wainwright & Co. Reiterates Buy on Joby Aviation, Maintains $9 Price Target

Benzinga55minutes ago · Ratings

Joby Aviation Analyst Ratings

Benzinga57minutes ago · Ratings

Fluence Energy Analyst Ratings

Benzinga18:43 · Ratings